Idiopathic multicentric Castleman disease: a mysterious case of generalized lymphadenopathy

نویسندگان

چکیده

Castleman disease is a syndrome with significant clinico-pathological overlap between malignancy, autoimmune causes and infectious etiologies. It spectrum can vary in extent from unicentric to multicentric generalized lymphadenopathy, organ involvement, constitutional symptoms cytopenias, severity non-severe severe TAFRO symptoms. Idiopathic (iMCD) diagnosis of exclusion after multiple as per diagnostic criteria are excluded. Treatment varies the types anti-IL 6 antibodies for cytotoxic chemotherapy agents We hereby report case type iMCD prolonged course delayed arrival at diagnosis, owing rarity this condition, which stresses need reduced threshold consider MCD, early differential diagnosis. Interestingly there were positive auto-antibodies elevated IgG4 levels patient, but applying strict helps distinguish

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Chronic Myelomonocytic Leukemia following Multicentric Castleman Disease

Multicentric Castleman disease (MCD) is a rare nonmalignant lymphoproliferative disorder presenting systemic symptoms such as fever, night sweats, fatigue, anemia, effusions, and multifocal lymphadenopathy. The etiology of MCD has not been clarified to date. The coexistence of MCD with chronic myelomonocytic leukemia (CMML) has been rarely reported. Although the pathogenesis remains unclear, th...

متن کامل

Siltuximab for Multicentric Castleman Disease-Letter.

We read with great interest the article by Deisseroth and colleagues (1) focusing on the recent global approval of the monoclonal IL6 antibody siltuximab for the treatment of patients with HHV-8-, HIV-negative multicentric Castleman disease (MCD). Up to now, treatment options for this rare lymphoproliferative disorder are very limited. Lately, the phase III, double-blind, randomized trial of va...

متن کامل

Multicentric Castleman disease: consensus at last?

In collaboration with an international cohort of clinicians and pathologists who reviewed more than 240 cases, the authors concurred on a set of evidence-based criteria, thereby paving the way for a uniform approach to managing this enigmatic condition. In 1956, Castleman et al described clinicopathologic features of 13 asymptomatic patients who presented with a mediastinal mass. This form of u...

متن کامل

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cytokine storm often including interleukin-6. iMCD accounts for one third to one half of all cases of MCD and can occur in individuals...

متن کامل

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Multicentric Castleman's disease (MCD) describes a heterogeneous group of disorders involving proliferation of morphologically benign lymphocytes due to excessive proinflammatory hypercytokinemia, most notably of interleukin-6. Patients demonstrate intense episodes of systemic inflammatory symptoms, polyclonal lymphocyte and plasma cell proliferation, autoimmune manifestations, and organ system...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Research in Medical Sciences

سال: 2023

ISSN: ['2320-6012', '2320-6071']

DOI: https://doi.org/10.18203/2320-6012.ijrms20232455